What is the recommended follow-up for patients diagnosed with pityriasis rosea to monitor for potential complications?

Recommended follow-up for patients diagnosed with pityriasis rosea:

• For most patients, no specific follow-up is required as the rash typically resolves without treatment within 2–3 months and does not usually recur. Reassure patients about the natural course of the condition and provide information on symptom management, especially for itch ¹.
• Advise patients to seek further medical advice if the rash worsens, if there is severe or uncontrolled itch despite symptomatic treatment, or if the diagnosis is uncertain or atypical, as these situations may require specialist referral ¹.
• In cases of pityriasis rosea occurring during pregnancy, especially in the first 15 weeks, urgent referral to secondary care is recommended due to the risk of adverse outcomes such as miscarriage and premature delivery. Secondary care may consider further investigations and antiviral treatment ¹.
• Symptomatic treatment follow-up should focus on monitoring the effectiveness of emollients, topical corticosteroids, or oral antihistamines for itch relief, discontinuing antihistamines if no benefit is seen after 2 weeks ¹.
• There is no routine need for long-term monitoring for complications in typical cases, but patients should be informed about the possibility of post-inflammatory pigmentation changes and the low risk of recurrence ¹.